Chloroquine in fighting COVID-19: good, bad, or both?

Daolin Tang; Jingbo Li; Ruoxi Zhang; Rui Kang; Daniel J. Klionsky

doi:10.1080/15548627.2020.1796014

Chloroquine in fighting COVID-19: good, bad, or both?

Daolin Tang, Jingbo Li, Ruoxi Zhang, Rui Kang, Daniel J. Klionsky

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

Coronavirus disease 2019 (COVID-19) has attracted worldwide attention due to its speed of progression and elevated mortality rate. Amid the rush to develop treatments, recent hopes have focused on the anti-malarial drug chloroquine or the derivative hydroxychloroquine. Here, we briefly discuss the evidence for the potential use of these drugs with regard to the current pandemic.

Original language	English (US)
Pages (from-to)	2273-2275
Number of pages	3
Journal	Autophagy
Volume	16
Issue number	12
DOIs	https://doi.org/10.1080/15548627.2020.1796014
State	Published - 2020

Keywords

COVID-19
Chloroquine
SARS-CoV-2
autophagy
clinical trial
hydroxychloroquine

ASJC Scopus subject areas

Molecular Biology
Cell Biology

Access to Document

10.1080/15548627.2020.1796014

Cite this

@article{ed7f82a492a5461781427351f5beb2be,

title = "Chloroquine in fighting COVID-19: good, bad, or both?",

abstract = "Coronavirus disease 2019 (COVID-19) has attracted worldwide attention due to its speed of progression and elevated mortality rate. Amid the rush to develop treatments, recent hopes have focused on the anti-malarial drug chloroquine or the derivative hydroxychloroquine. Here, we briefly discuss the evidence for the potential use of these drugs with regard to the current pandemic.",

keywords = "COVID-19, Chloroquine, SARS-CoV-2, autophagy, clinical trial, hydroxychloroquine",

author = "Daolin Tang and Jingbo Li and Ruoxi Zhang and Rui Kang and Klionsky, {Daniel J.}",

note = "Publisher Copyright: {\textcopyright} 2020 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2020",

doi = "10.1080/15548627.2020.1796014",

language = "English (US)",

volume = "16",

pages = "2273--2275",

journal = "Autophagy",

issn = "1554-8627",

publisher = "Landes Bioscience",

number = "12",

}

TY - JOUR

T1 - Chloroquine in fighting COVID-19

T2 - good, bad, or both?

AU - Tang, Daolin

AU - Li, Jingbo

AU - Zhang, Ruoxi

AU - Kang, Rui

AU - Klionsky, Daniel J.

PY - 2020

Y1 - 2020

N2 - Coronavirus disease 2019 (COVID-19) has attracted worldwide attention due to its speed of progression and elevated mortality rate. Amid the rush to develop treatments, recent hopes have focused on the anti-malarial drug chloroquine or the derivative hydroxychloroquine. Here, we briefly discuss the evidence for the potential use of these drugs with regard to the current pandemic.

AB - Coronavirus disease 2019 (COVID-19) has attracted worldwide attention due to its speed of progression and elevated mortality rate. Amid the rush to develop treatments, recent hopes have focused on the anti-malarial drug chloroquine or the derivative hydroxychloroquine. Here, we briefly discuss the evidence for the potential use of these drugs with regard to the current pandemic.

KW - COVID-19

KW - Chloroquine

KW - SARS-CoV-2

KW - autophagy

KW - clinical trial

KW - hydroxychloroquine

UR - http://www.scopus.com/inward/record.url?scp=85086927425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086927425&partnerID=8YFLogxK

U2 - 10.1080/15548627.2020.1796014

DO - 10.1080/15548627.2020.1796014

M3 - Article

C2 - 32713288

AN - SCOPUS:85086927425

SN - 1554-8627

VL - 16

SP - 2273

EP - 2275

JO - Autophagy

JF - Autophagy

IS - 12

ER -

Chloroquine in fighting COVID-19: good, bad, or both?

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this